Paradigm Biocapital Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-85,000	Closed	-$19.6M	–	31
2023 Q2	$19.6M	Buy	+85,000	New	+$19.6M	1.52%	25